(MedPage Today) -- The FDA expanded the approval of leucovorin calcium (Wellcovorin) tablets to treat FOLR1-related cerebral folate transport deficiency (CFD-FOLR1), an ultra-rare hereditary disorder, the agency announced Tuesday. Leucovorin...
Read more



















